Literature DB >> 33542049

Determinants of lung disease progression measured by lung clearance index in children with cystic fibrosis.

Sanja Stanojevic1,2, Stephanie D Davis3, Lucy Perrem4, Michelle Shaw1, George Retsch-Bogart3, Miriam Davis3, Renee Jensen1, Charles C Clem5, Sarah M Isaac1, Julia Guido1, Sylvia Jara5, Lisa France5, Nancy McDonald1, Melinda Solomon4, Neil Sweezey4, Hartmut Grasemann4, Valerie Waters1,6, D B Sanders5, Felix A Ratjen1,4.   

Abstract

The lung clearance index (LCI) measured by the multiple breath washout (MBW) test is sensitive to early lung disease in children with cystic fibrosis. While LCI worsens during the preschool years in cystic fibrosis, there is limited evidence to clarify whether this continues during the early school age years, and whether the trajectory of disease progression as measured by LCI is modifiable.A cohort of children (healthy and cystic fibrosis) previously studied for 12 months as preschoolers were followed during school age (5-10 years). LCI was measured every 3 months for a period of 24 months using the Exhalyzer D MBW nitrogen washout device. Linear mixed effects regression was used to model changes in LCI over time.A total of 582 MBW measurements in 48 healthy subjects and 845 measurements in 64 cystic fibrosis subjects were available. The majority of children with cystic fibrosis had elevated LCI at the first preschool and first school age visits (57.8% (37 out of 64)), whereas all but six had normal forced expiratory volume in 1 s (FEV1) values at the first school age visit. During school age years, the course of disease was stable (-0.02 units·year-1 (95% CI -0.14-0.10). LCI measured during preschool years, as well as the rate of LCI change during this time period, were important determinants of LCI and FEV1, at school age.Preschool LCI was a major determinant of school age LCI; these findings further support that the preschool years are critical for early intervention strategies.
Copyright ©ERS 2021. For reproduction rights and permissions contact permissions@ersnet.org.

Entities:  

Year:  2021        PMID: 33542049     DOI: 10.1183/13993003.03380-2020

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  3 in total

Review 1.  ERS International Congress 2021: highlights from the Paediatric Assembly.

Authors:  Cristina Ardura-Garcia; Alicia Abellan; Sara Cuevas-Ocaña; Nadine Freitag; Yin Ting Lam; Heidi Makrinioti; Monique Slaats; Matteo Storti; Emma E Williams; Theodore Dassios; Liesbeth Duijts; Refika H Ersu; Stojka Fustik; Rory E Morty; Marijke Proesmans; Dirk Schramm; Sejal Saglani; Alexander Moeller; Marielle W Pijnenburg
Journal:  ERJ Open Res       Date:  2022-05-23

2.  Multiple breath washout: measuring early manifestations of lung pathology.

Authors:  Sanja Stanojevic; Cole Bowerman; Paul Robinson
Journal:  Breathe (Sheff)       Date:  2021-09

3.  Longitudinal assessment of lung clearance index to monitor disease progression in children and adults with cystic fibrosis.

Authors:  Alex R Horsley; John Belcher; Katie Bayfield; Brooke Bianco; Steve Cunningham; Catherine Fullwood; Andrew Jones; Anna Shawcross; Jaclyn A Smith; Anirban Maitra; Francis J Gilchrist
Journal:  Thorax       Date:  2021-07-22       Impact factor: 9.139

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.